GMCL1 controls 53BP1 stability and modulates taxane sensitivity
eLife · 2026
DOI: 10.7554/elife.106730 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2026. Verfasst von Yuki Kito und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, United States. Hauptthemen laut MEDLINE: Tumor Suppressor p53-Binding Protein 1, Paclitaxel, Taxoids. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United States Department of Defense, NCI NIH HHS, Hungarian Research Network.
Abstract (Originalsprache)
Mitotic surveillance pathways monitor the duration of mitosis (M phase) in the cell cycle. Prolonged M phase, caused by spindle attachment defects or microtubule-targeting drugs, triggers formation of the ternary ‘mitotic stopwatch pathway’ complex (MSP) consisting of 53BP1, USP28, and p53. This complex stabilizes p53, leading to cell cycle arrest or apoptosis in daughter cells. In cancers that are resistant to paclitaxel, a microtubule-targeting agent, cells bypass mitotic surveillance activation, allowing unchecked proliferation, although the underlying mechanisms remain poorly understood. Here, we identify GMCL1 as a key negative regulator of MSP signaling. We show that 53BP1 physically interacts with GMCL1, but not its paralog GMCL2, and we map their interaction domains. CRL3 GMCL1 functions as a ubiquitin ligase that targets 53BP1 for degradation during the M phase, thereby reducing p53 accumulation in daughter cells. Depletion of GMCL1 inhibits cell cycle progression upon release from prolonged mitotic arrest, a defect that is rescued by co-silencing 53BP1 or USP28. Moreover, GMCL1 depletion sensitizes cancer cells to paclitaxel in a p53-dependent manner. Together, our findings support a model in which dysregulated CRL3 GMCL1 -mediated degradation of 53BP1 prevents proper MSP function, leading to p53 degradation and continued proliferation. Targeting GMCL1 may, therefore, represent one possible avenue for addressing paclitaxel resistance in cancer cells with functional p53.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, United States.
- Laura and Isaac Perlmutter Cancer Center, New York University Grossman School of Medicine, New York, United States.
- Division of Precision Medicine, Department of Medicine, NYU Grossman School of Medicine, New York, United States.
- Howard Hughes Medical Institute, NYU Grossman School of Medicine, New York, United States.
- Department of Cell Biology, New York University Grossman School of Medicine, New York, United States.
- Proteomics Laboratory, Division of Advanced Research Technologies, New York University Grossman School of Medicine, New York, United States.
ORCID-Profile: Yuki Kito, Tania J González-Robles, Sharon Kaisari, Beatrix Ueberheide, Antonio Marzio, Gergely Róna, Michele Pagano
Förderung
- United States Department of Defense
- NCI NIH HHS
- Hungarian Research Network
- NIGMS NIH HHS
- Howard Hughes Medical Institute
- NIH HHS
- NIH Office of the Director
- European Molecular Biology Organization
Zitieren
APA
Kito, Y., González-Robles, T. J., Kaisari, S., Pae, J., Garcia, S. F., Ortiz-Pacheco, J., Ueberheide, B., Marzio, A., Róna, G., & Pagano, M. (2026). GMCL1 controls 53BP1 stability and modulates taxane sensitivity. eLife. https://doi.org/10.7554/elife.106730
Vancouver
Kito Y, González-Robles TJ, Kaisari S, Pae J, Garcia SF, Ortiz-Pacheco J, et al. GMCL1 controls 53BP1 stability and modulates taxane sensitivity. eLife. 2026. doi:10.7554/elife.106730
BibTeX
@article{Kito2026,
author = {Kito, Yuki and González-Robles, Tania J and Kaisari, Sharon and Pae, Juhee and Garcia, Sheena Faye and Ortiz-Pacheco, Juliana and Ueberheide, Beatrix and Marzio, Antonio and Róna, Gergely and Pagano, Michele},
title = {GMCL1 controls 53BP1 stability and modulates taxane sensitivity},
journal = {eLife},
year = {2026},
doi = {10.7554/elife.106730}
}
EUVIMED